Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyRemission InductionTreatment OutcomeDisease-Free SurvivalCytarabineSalvage TherapyStem CellsEtoposideCyclophosphamideRecurrenceHodgkin DiseaseLymphoma, Non-HodgkinMyeloablative AgonistsVincristineSurvival RateBone Marrow TransplantationCarmustineSurvival AnalysisHematopoietic Stem Cell MobilizationGraft vs Host DiseaseThiotepaBone Marrow PurgingHematologic NeoplasmsInduction ChemotherapyDoxorubicinRetrospective StudiesWhole-Body IrradiationDexamethasoneBoronic AcidsLymphoma, Mantle-CellPrognosisGraft SurvivalPyrazinesAmyloidosisHematopoietic Stem CellsAntibodies, Monoclonal, Murine-DerivedBusulfanFollow-Up StudiesThalidomidePrednisoneAntineoplastic AgentsAntineoplastic Agents, AlkylatingLymphoma, FollicularTime FactorsMaintenance ChemotherapyLiver TransplantationAntigens, CD34Leukemia, Myeloid, AcuteAutograftsIfosfamideLymphoma, T-Cell, PeripheralNeoplasm, ResidualGranulocyte Colony-Stimulating FactorIdarubicinMesenchymal Stem Cell TransplantationLymphomaKidney TransplantationLeukapheresisImmunosuppressive AgentsPodophyllotoxinMitoxantroneTissue DonorsTransplantation ChimeraLymphoma, Large B-Cell, DiffuseCord Blood Stem Cell TransplantationCell TransplantationMyelodysplastic SyndromesLeukemia, MyeloidCisplatinAntibodies, MonoclonalProspective StudiesDrug Administration SchedulePrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem CellsLymphoma, B-CellEnteropathy-Associated T-Cell LymphomaCarboplatinLeukemia, Plasma CellNeoplasms, Second PrimaryInfusions, SpinalAcute DiseaseGraft RejectionAdult Stem CellsNeoplasm Recurrence, LocalFeasibility StudiesAntilymphocyte SerumBlood Component RemovalLife TablesChemotherapy, AdjuvantHistocompatibility TestingLeukemia